Article

The Cost-effectiveness of One-step Point-of-care Hepatitis C Virus RNA Testing in the United States

2025-09-29

Abstract excerpt

<h4>Background</h4> The standard of care (SOC) two-step laboratory-based hepatitis C virus (HCV) diagnostic algorithm is associated with high rates of undiagnosed cases, patients lost to follow-up, and low rates of treatment initiation. This study examines the cost-effectiveness of a one-step point-of-care HCV RNA diagnostic strategy (POC_RNA) compared to SOC across distinct settings of care serving people at hig...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 579e5e20-a02c-59fa-a0a0-24f175fed8c4
DOI: 10.1101/2025.09.27.25336816

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Cost-effectiveness of One-step Point-of-care Hepatitis C Virus RNA Testing in the United StatesDOI 10.1101/2025.09.27.25336816Read

Cost and cost-effectiveness of Hepatitis C virus self-testing in four settings: an economic evaluationSemantic proximity Read

Cost and cost-effectiveness of alternative screening and diagnostic pathways for achieving hepatitis C elimination in the country of GeorgiaSemantic proximity Read

Estimating the Cost-Effectiveness of One-Time Screening and Treatment for Hepatitis C in Korea.Semantic proximity Read

Cost-effectiveness of currently recommended direct-acting antiviral treatments in patients infected with genotypes 1 or 4 hepatitis C virus in the US.Semantic proximity Read

Cost-effectiveness and population outcomes of general population screening for hepatitis C.Semantic proximity Read

Assessing the potential cost-effectiveness of centralized vs point-of-care testing for hepatitis C virus in Pakistan: a model-based comparisonSemantic proximity Read

Real-World Impact of a Simplified 'Test and Treat' Strategy for In-Hospital HCV Micro-Elimination.Semantic proximity Read

Hepatitis C Core Antigen test as an alternative for diagnosing HCV infection: mathematical model and cost-effectiveness analysisSemantic proximity Read

Cost-effectiveness of Early Treatment of Hepatitis C Virus Genotype 1 by Stage of Liver Fibrosis in a US Treatment-Naive Population.Semantic proximity Read

Cost-effectiveness of IL28Β genotype-guided protease inhibitor triple therapy versus standard of care treatment in patients with hepatitis C genotypes 2 or 3 infection.Semantic proximity Read

Cost-Effectiveness of Genotype 1 Chronic Hepatitis C Virus Treatments in Patients Coinfected with Human Immunodeficiency Virus in the United States.Semantic proximity Read

Non-pharmacologic direct cost of a simplified strategy with glecaprevir/pibrentasvir for 8 weeks in naïve non-cirrhotic patients with hepatitis C implemented in clinical practice. The Just SIMPLE Study.Semantic proximity Read